Introduction: Chromosomal disorders such as trisomy 21 (most common), 18 and 13 are a source of concern for parents, in terms of fetal health, delivery/miscarriage; this may be compounded by concerns about financial issues. These concerns increase with the age of the mother (1,2). Prenatal screening is used to assess the likelihood of having a fetus with such anomaly(ies) and if necessary further diagnostic tests.

Candide Ahouehome
M.Sc. candidate
Faculté de médecine
Université Laval
Introduction: Chromosomal disorders such as trisomy 21 (most common), 18 and 13 are a source of concern for parents, in terms of fetal health, delivery/miscarriage; this may be compounded by concerns about financial issues. These concerns increase with the age of the mother (1,2). Prenatal screening is used to assess the likelihood of having a fetus with such anomaly(ies) and if necessary further diagnostic tests. Previous studies have shown that pregnant women actively seek information to make informed decisions about testing: what options are available? Are they prepared enough to make a choice? Do they have all the necessary information? How can their own values and preferences be considered?
Effective decision support tools exist to help people facing difficult decisions to make informed choices (4). However, the evidence contained in these tools has not been evaluated based on the relative weight it contributes to the decision to be made. Furthermore, the intentions of pregnant women and their partners to use such a tool in a digital format are unknown (5).
Objective: The main objective of our study is to assess the intention of pregnant women and/or their partners to use a mobile application-based decision support tool for prenatal screening. More specifically, it will: identify potential factors that may influence decision making; assess the relative weight of the information contained in the tool ascribed by pregnant women and/or their partners; and assess their intention to use it.
Methods: Study design: This is a descriptive cross-sectional study that represents phase 1 of a project called APP4WE (Analytical mobile application to support shared decision making for pregnant women) of the Canada Research Chair in Shared Decision Making and Knowledge Translation (6). This project aims to enable pregnant women and their partners to get the support they need to make informed decisions about prenatal screening and includes several phases. Participants and sample size: For phase 1, we propose to recruit an independent sample of 90 pregnant women and their partners from three clinical sites (a midwife-led birthing centre, a family practice clinic, and an obstetrician-led hospital clinic) in Quebec City and Montreal, Canada. Pregnant women and their partners will be recruited to reflect the respective proportions of socio-economic, ethnic, and linguistic communities. To be eligible for the study, pregnant women must be at least 18 years old, more than 20 weeks pregnant, have a low-risk pregnancy, not have given birth near the dates of data collection, be able to speak and write French or English and be able to give informed consent. Partners of pregnant women will also be asked to provide informed consent. Measured outcome: The primary outcome of this study is to measure the intention of pregnant women and/or their partners to use a mobile application for prenatal screening decision making. To assess this outcome, the Continuing Professional Development - Feedback (CPD-Feedback) questionnaire was used. This tool is a validated 12-item questionnaire that assesses the impact of continuing professional development activities on the clinical behavioural intentions of health professionals. We will also determine the factors (socio-demographic and others) potentially associated with intention. Statistical analysis: We will first perform descriptive statistics to determine the characteristics of our study population and the distribution of intention. Subsequently, a linear mixed model will be used to determine potential factors influencing the intention of pregnant women and/or their partners to use a mobile application for prenatal screening decision making. We will specify random effects at the practice level (cluster), which will allow us to answer our research question while considering the hierarchical structure of the study.
Références :
1. Ohman SG, Grunewald C, Waldenström U. Women's worries during pregnancy: testing the Cambridge Worry Scale on 200 Swedish women. Scand J Caring Sci. 2003 Jun;17(2):148-52. doi: 10.1046/j.1471-6712.2003.00095.x. PMID: 12753515
2. Practice Bulletin No. 163: Screening for Fetal Aneuploidy. Obstet Gynecol. 2016 May;127(5): e123-e137. doi: 10.1097/AOG.0000000000001406. PMID: 26938574.
3. Légaré F, St-Jacques S, Gagnon S, Njoya M, Brisson M, Frémont P, Rousseau F. Prenatal screening for Down syndrome: a survey of willing in women and family physicians to engage in shared decision-making. Prenat Diagn. 2011 Avr;31(4):319-26. doi: 10.1002/.2624. EPUB 2011 Jan 26. PMID : 21268046.
4. Agbadje TT, Pilon C, Bérubé P, Forest JC, Rousseau F, Rahimi SA, Giguère Y, Légaré F. User Experience of a Computer-Based Decision Aid for Prenatal Trisomy Screening: Mixed Methods Explanatory Study. JMIR Pediatr Parent. 6 septembre 2022;5(3):e35381. doi : 10.2196/35381. PMID : 35896164; Numéro PMCID : PMC9490528.
5. Delanoë A, Lépine J, Turcotte S, Leiva Portocarrero ME, Robitaille H, Giguère AM, Wilson BJ, Witteman HO, Lévesque I, Guillaumie L, Légaré F. Rôle des facteurs psychosociaux et de la littératie en santé dans l’intention des femmes enceintes d’utiliser un outil d’aide à la décision pour le dépistage du syndrome de Down : un sondage en ligne fondé sur la théorie. 2016 Oct 28;18(10):e283. doi : 10.2196/jmir.6362. PMID : 27793792; PMCID : PMC5106559.
6. Abbasgholizadeh Rahimi S, Lépine J, Croteau J, Robitaille H, Giguere AM, Wilson BJ, Rousseau F, Lévesque I, Légaré F. Facteurs psychosociaux de l’intention des professionnels de la santé d’utiliser un outil d’aide à la décision pour le dépistage du syndrome de Down : étude quantitative transversale. 2018 Apr 25;20(4):e114. doi : 10.2196/jmir.9036. PMID : 29695369; PMCID : PMC5943629.

Leonardo Di Schiavi Trotta
Ph.D. candidate
Faculté des sciences et de génie
Université Laval
Duel-energy Computed Tomography (CT) imaging has the potential to better characterize materials. DE CT images would allow for a more accurate identification of tissues present in the human anatomy. The presence of highdensity elements (e.g. region of the shoulder, posterior fossa, metallic inserts, etc.) in the scanned subject causes deterioration of the CT image quality (e.g. beam-hardening artifacts). The polychromatic nature of the X-ray beam used in CT scanners is the origin of some image artifacts. In this work, we propose a physics-rich polychromatic projection model that uses the spectrum information, the detector response, the filter geometry and a calibration curve. This model is embedded in an iterative reconstruction algorithm, and inherently reduces beam-hardening artifacts. With dual-energy acquisitions, one can reconstruct quantitative images, with effective atomic number, and electron density information. Besides that, various reconstructions techniques are explored, so high-quality images can be obtained with less artifacts, ultimately, improving the characterization and identification of elements in the image.
Duel-energy Computed Tomography (CT) imaging has the potential to better characterize materials. DE CT images would allow for a more accurate identification of tissues present in the human anatomy. The presence of highdensity elements (e.g. region of the shoulder, posterior fossa, metallic inserts, etc.) in the scanned subject causes deterioration of the CT image quality (e.g. beam-hardening artifacts). The polychromatic nature of the X-ray beam used in CT scanners is the origin of some image artifacts.
Cancer patient peer support is a beneficial tool for current patients and previous patients who can share lived experiences. However, current peer support is inefficient as it is conducted manually and relies on a coordinator to match patients based on a few known factors.
Patient portal is an emerging healthcare technology that has shown promising effects in enhancing patient care experience and promoting patient health outcomes. Opal, a digital patient-centred portal, is currently available to patients at the Cedars Cancer Center at McGill University Health Centre (MUHC), providing real-time access to personal health information (upcoming appointments, clinical notes, lab results, etc.) in conjunction with the disease- and treatment-specific education materials.
The risk associated with the stochastic effects of neutron radiation is known to be strongly energy dependent. Over the past decade, several studies have used Monte Carlo simulations to estimate the relative biological effectiveness (RBE) of neutrons for various types of DNA damage in order to understand its energy dependence at the fundamental level. However, none of these studies implemented DNA repair simulations in their pipeline.
Cancer patients go through a lot during treatment. Many patients need support from other patients who know what they are going through because family and friends, no matter how supportive they try to be, don’t always understand their struggles.
The cancer experience and the uncertainty surrounding it is anxiety provoking. One way in which the non-clinical uncertainty of the cancer experience can be reduced is through peer support. The Opal Health Informatics Group seeks to evaluate the efficacy of an artificial intelligence-based peer support matching algorithm in the pre-existing patient portal Opal in the hopes of facilitating peer support programs (for cancer patients and their caregivers) in Quebec.
La rédaction scientifique de manuscrits et d’abstracts
Know moreDiscover

Featured project
This research project is based on the analysis of massive data on the NOL index and other intraoperative clinical parameters used by anesthesiologists during surgery. These parameters help them make analgesic treatment decisions in a non-communicating patient under general anesthesia and in whom it is impossible to assess pain and analgesic needs by standard questionnaires performed on awake patients.
First, the objective is to interpret the values of this index in relation to the decisions made by the clinician.